[HTML][HTML] Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment
Comorbid mental disorders in subjects at clinical high risk for psychosis (CHR-P) may
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment
M Solmi, L Soardo, S Kaur, M Azis… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Comorbid mental disorders in subjects at clinical high risk for psychosis (CHR-P) may
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment
M Solmi, L Soardo, S Kaur, M Azis, A Cabras… - MOLECULAR …, 2023 - iris.unipv.it
: Comorbid mental disorders in subjects at clinical high risk for psychosis (CHR-P) may
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: The case for transdiagnostic assessment.
M Solmi, L Soardo, S Kaur, M Azis, A Cabras… - Molecular …, 2023 - psycnet.apa.org
Comorbid mental disorders in subjects at clinical high risk for psychosis (CHR-P) may
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.
M Solmi, L Soardo, S Kaur, M Azis, A Cabras… - Molecular …, 2023 - europepmc.org
Comorbid mental disorders in subjects at clinical high risk for psychosis (CHR-P) may
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of 9 psychosis: the case for transdiagnostic assessment
M Solmi, L Soardo, S Kaur, M Azis, A Cabras… - Molecular …, 2023 - kclpure.kcl.ac.uk
Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of 9
psychosis: the case for transdiagnostic assessment — King's College London Skip to main …
psychosis: the case for transdiagnostic assessment — King's College London Skip to main …
[HTML][HTML] Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment
M Solmi, L Soardo, S Kaur, M Azis, A Cabras… - Molecular …, 2023 - ncbi.nlm.nih.gov
Comorbid mental disorders in subjects at clinical high risk for psychosis (CHR-P) may
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.
M Solmi, L Soardo, S Kaur, M Azis, A Cabras… - Molecular …, 2023 - europepmc.org
Comorbid mental disorders in subjects at clinical high risk for psychosis (CHR-P) may
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …